🇺🇸 FDA
Patent

US 12049670

Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof

granted A61KA61K38/04A61P

Quick answer

US patent 12049670 (Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/04, A61P, A61P3/04